TCL Archive FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC. March 30, 2001
TCL Archive Adding Velcade Increased Overall Survival By 13.3 Months at Five-Year Analysis December 30, 2011
